Gene Therapy - Medika Life

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

India: The Growing Focal Point for Health Innovation

2024 Health Trends: Progress, Challenges, and Opportunities

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

When It Comes to the Future of HLTH – Life Is Not a Las Vegas Roulette Wheel

LATEST

TRENDING

When It Comes to the Future of HLTH – Life Is Not a Las Vegas Roulette Wheel

Central Dogma has Lost its Dog

Perhaps, A Braver New World

The Fluoroscope Serves as a Warning for New Medical Technology

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

2024 Health Trends: Progress, Challenges, and Opportunities

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Qatar Genome Research Consortium Reports First and Largest Comprehensive Genetic Association Study in Middle East

Elon Musk, Can You Save Us From Covid 2.0?

EDITORS CHOICE

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

2024 Health Trends: Progress, Challenges, and Opportunities

India: The Growing Focal Point for Health Innovation

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories